Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ZeMac histoanalys AB
AB
In liquidation
Org 5568292170
Research and experimental development on biotechnology
· NACE 7211
Est. 2010
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
ZeMac histoanalys AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (5)
IM
Inger Margareta Dahle
External Signatory
External Signatory
2022
BE
Barbro Elisabeth Hansson
External Signatory
External Signatory
2022
BJ
Bengt Junior Niklas Nygårds
External Signatory
External Signatory
2020
KO
Knut Olof Mikael Rosén
Liquidator
Liquidator
2022
UM
Ulrika Margareta Ahlholm
External Signatory
External Signatory
2020
Former (1)
LG
Leif Gustav Andersson
External Signatory
External Signatory
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
BS
Baris Sagici
Deputy Board Member
2020 – 2022
MS
Mahbule Sagici
Board of Directors
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ZeMac histoanalys AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network